Udg Healthcare PLC (UDG) Price Target Raised to GBX 700
Udg Healthcare PLC (LON:UDG) had its target price raised by Berenberg Bank from GBX 655 ($8.11) to GBX 700 ($8.66) in a report released on Friday morning. Berenberg Bank currently has a buy rating on the stock.
Several other equities research analysts have also recently weighed in on the stock. Jefferies Group increased their price target on shares of Udg Healthcare PLC from GBX 680 ($8.42) to GBX 720 ($8.91) and gave the company a buy rating in a research report on Friday, September 30th. Stifel Nicolaus reissued a hold rating and set a GBX 620 ($7.67) price target on shares of Udg Healthcare PLC in a research report on Wednesday, September 28th. Goodbody reissued a buy rating on shares of Udg Healthcare PLC in a research report on Thursday, August 4th. Davy Research reissued an outperform rating on shares of Udg Healthcare PLC in a research report on Thursday, August 4th. Finally, Numis Securities Ltd reissued an add rating and set a GBX 675 ($8.35) price target on shares of Udg Healthcare PLC in a research report on Wednesday, September 28th. Two research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Udg Healthcare PLC has an average rating of Buy and a consensus target price of GBX 666 ($8.24).
Udg Healthcare PLC (LON:UDG) opened at 642.50 on Friday. The firm’s market capitalization is GBX 1.58 billion. The stock’s 50 day moving average is GBX 632.93 and its 200-day moving average is GBX 604.37. Udg Healthcare PLC has a one year low of GBX 452.20 and a one year high of GBX 663.00.
In other Udg Healthcare PLC news, insider Chris Corbin sold 90,849 shares of the company’s stock in a transaction on Monday, September 26th. The shares were sold at an average price of GBX 634 ($7.85), for a total value of £575,982.66 ($712,849.83).
Udg Healthcare PLC Company Profile
UDG Healthcare plc, formerly United Drug plc, is a healthcare services provider in the Republic of Ireland, the United Kingdom, North America and Continental Europe. The Company operates in three segments. The Ashfield Commercial & Medical Services segment is engaged in the provision of sales, marketing and healthcare communications services to pharmaceutical companies, and it also provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services to over 300 healthcare companies in approximately 20 countries.
Receive News & Ratings for Udg Healthcare PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare PLC and related companies with MarketBeat.com's FREE daily email newsletter.